Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 144

1.

The role of 17beta-hydroxysteroid dehydrogenases in modulating the activity of 2-methoxyestradiol in breast cancer cells.

Newman SP, Ireson CR, Tutill HJ, Day JM, Parsons MF, Leese MP, Potter BV, Reed MJ, Purohit A.

Cancer Res. 2006 Jan 1;66(1):324-30.

PMID:
16397246
[PubMed - indexed for MEDLINE]
Free Article
2.
3.

New development in intracrinology of breast carcinoma.

Sasano H, Suzuki T, Nakata T, Moriya T.

Breast Cancer. 2006;13(2):129-36. Review.

PMID:
16755106
[PubMed - indexed for MEDLINE]
Free Article
5.

Expression of aromatase and 17beta-hydroxysteroid dehydrogenase types 1, 7 and 12 in breast cancer. An immunocytochemical study.

Song D, Liu G, Luu-The V, Zhao D, Wang L, Zhang H, Xueling G, Li S, Désy L, Labrie F, Pelletier G.

J Steroid Biochem Mol Biol. 2006 Oct;101(2-3):136-44. Epub 2006 Aug 22.

PMID:
16930994
[PubMed - indexed for MEDLINE]
6.

17beta-hydroxysteroid dehydrogenase Type 1, and not Type 12, is a target for endocrine therapy of hormone-dependent breast cancer.

Day JM, Foster PA, Tutill HJ, Parsons MF, Newman SP, Chander SK, Allan GM, Lawrence HR, Vicker N, Potter BV, Reed MJ, Purohit A.

Int J Cancer. 2008 May 1;122(9):1931-40. doi: 10.1002/ijc.23350.

PMID:
18183589
[PubMed - indexed for MEDLINE]
7.

Reductive 17beta-hydroxysteroid dehydrogenases in the sulfatase pathway: critical in the cell proliferation of breast cancer.

Aka JA, Mazumdar M, Lin SX.

Mol Cell Endocrinol. 2009 Mar 25;301(1-2):183-90. doi: 10.1016/j.mce.2008.10.042. Epub 2008 Nov 7. Review.

PMID:
19038308
[PubMed - indexed for MEDLINE]
8.

Pharmacokinetics and efficacy of 2-methoxyoestradiol and 2-methoxyoestradiol-bis-sulphamate in vivo in rodents.

Ireson CR, Chander SK, Purohit A, Perera S, Newman SP, Parish D, Leese MP, Smith AC, Potter BV, Reed MJ.

Br J Cancer. 2004 Feb 23;90(4):932-7.

PMID:
14970876
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Relative involvement of three 17beta-hydroxysteroid dehydrogenases (types 1, 7 and 12) in the formation of estradiol in various breast cancer cell lines using selective inhibitors.

Laplante Y, Rancourt C, Poirier D.

Mol Cell Endocrinol. 2009 Mar 25;301(1-2):146-53. doi: 10.1016/j.mce.2008.08.026. Epub 2008 Sep 4.

PMID:
18812208
[PubMed - indexed for MEDLINE]
10.
11.

Expression of 17beta-hydroxysteroid dehydrogenase type 2 and type 5 in breast cancer and adjacent non-malignant tissue: a correlation to clinicopathological parameters.

Han B, Li S, Song D, Poisson-Paré D, Liu G, Luu-The V, Ouellet J, Li S, Labrie F, Pelletier G.

J Steroid Biochem Mol Biol. 2008 Dec;112(4-5):194-200. doi: 10.1016/j.jsbmb.2008.10.004. Epub 2008 Oct 19.

PMID:
18996480
[PubMed - indexed for MEDLINE]
12.

Inhibitors of type 1 17beta-hydroxysteroid dehydrogenase with reduced estrogenic activity: modifications of the positions 3 and 6 of estradiol.

Tremblay MR, Boivin RP, Luu-The V, Poirier D.

J Enzyme Inhib Med Chem. 2005 Apr;20(2):153-63.

PMID:
15968820
[PubMed - indexed for MEDLINE]
13.

Estrogen metabolism and malignancy: analysis of the expression and function of 17beta-hydroxysteroid dehydrogenases in colonic cancer.

English MA, Stewart PM, Hewison M.

Mol Cell Endocrinol. 2001 Jan 22;171(1-2):53-60. Review.

PMID:
11165011
[PubMed - indexed for MEDLINE]
14.

Systemic distribution and tissue localizations of human 17beta-hydroxysteroid dehydrogenase type 12.

Sakurai N, Miki Y, Suzuki T, Watanabe K, Narita T, Ando K, Yung TM, Aoki D, Sasano H, Handa H.

J Steroid Biochem Mol Biol. 2006 Jun;99(4-5):174-81. Epub 2006 Apr 18.

PMID:
16621523
[PubMed - indexed for MEDLINE]
15.

Mammalian lignans and genistein decrease the activities of aromatase and 17beta-hydroxysteroid dehydrogenase in MCF-7 cells.

Brooks JD, Thompson LU.

J Steroid Biochem Mol Biol. 2005 Apr;94(5):461-7. Epub 2005 Mar 16.

PMID:
15876411
[PubMed - indexed for MEDLINE]
16.

Development of hormone-dependent prostate cancer models for the evaluation of inhibitors of 17beta-hydroxysteroid dehydrogenase type 3.

Day JM, Tutill HJ, Foster PA, Bailey HV, Heaton WB, Sharland CM, Vicker N, Potter BV, Purohit A, Reed MJ.

Mol Cell Endocrinol. 2009 Mar 25;301(1-2):251-8. doi: 10.1016/j.mce.2008.08.014. Epub 2008 Aug 22.

PMID:
18786604
[PubMed - indexed for MEDLINE]
17.

17Beta-hydroxysteroid dehydrogenase type 1 and type 2 in human breast carcinoma: a correlation to clinicopathological parameters.

Suzuki T, Moriya T, Ariga N, Kaneko C, Kanazawa M, Sasano H.

Br J Cancer. 2000 Feb;82(3):518-23.

PMID:
10682658
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

2-MeOE2bisMATE and 2-EtE2bisMATE induce cell cycle arrest and apoptosis in breast cancer xenografts as shown by a novel ex vivo technique.

Foster PA, Ho YT, Newman SP, Kasprzyk PG, Leese MP, Potter BV, Reed MJ, Purohit A.

Breast Cancer Res Treat. 2008 Sep;111(2):251-60. Epub 2007 Oct 24.

PMID:
17957467
[PubMed - indexed for MEDLINE]
19.
20.

Effects of phytoestrogens on aromatase, 3beta and 17beta-hydroxysteroid dehydrogenase activities and human breast cancer cells.

Le Bail JC, Champavier Y, Chulia AJ, Habrioux G.

Life Sci. 2000 Feb 25;66(14):1281-91.

PMID:
10755463
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk